The U.S. Food and Drug Administration yesterday approved Anthrasil, Anthrax Immune Globulin Intravenous (Human), to treat patients with inhalational anthrax in combination with appropriate antibacterial drugs. Inhalational anthrax is a rare disease that can occur after exposure to infected…
Source:FDA approves treatment for inhalation anthrax
Wednesday, March 25, 2015
FDA approves treatment for inhalation anthrax
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment